Avalign Technologies announced that is has acquired Thortex and Millennium Surgical. The financial details of the deal were not disclosed.
Thortex provides precision manufacturing, porous coatings and metal injection solutions to the medical device market. It has porous coating solutions for titanium and cobalt-chrome orthopedic implants and manufacturing and engineering technologies for medical device OEMs.
Millennium Surgical offers specialty surgical instruments and more than 17,000 branded SKUs in a variety of clinical areas like neurosurgery, ophthalmics and orthopedics.
“The incorporation of Thortex and Millennium into the Avalign platform adds new and proprietary capabilities which enhance Avalign’s strategic position in the marketplace,” said Matt Altman, a managing partner at Avalign’s portfolio company Arlington Capital, in a press release. “The increased scale and breadth of services and technologies provided by these acquisitions will accrue to the benefit of Avalign’s customers and bolster Avalign’s already impressive growth.”
“Thortex and Millennium nicely complement and expand the manufacturing technologies and services that Avalign offers and provide us with the ability to continue gaining share with our customers,” said Forrest Whittaker, CEO of Avalign Technologies. “We are excited to welcome the Thortex and Millennium teams to the Avalign family, and thankful for Arlington’s support in consummating these highly strategic acquisitions.”
[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]
